It’s probably just a matter of time before a new company combines the rapidly advancing technologies of genome sequencing, genetic diagnostics, and Big Data to become the Google of bioinformatics.
Cypher Genomics would like to claim that title, though it’s too... Read more »
Sarepta Therapeutics is already one of the most controversial, volatile stocks in the biotech sector. And the Cambridge, MA-based company is in for another rocky day today, as a regulatory filing revealed that the company has axed chief scientific officer and... Read more »
The unfortunate few infected by Ebola learn quickly that the rare disease is a near-certain death sentence. Outbreaks have led to fatality rates up to 90 percent, according to the World Health Organization. Treatment options are limited: no approved vaccines or... Read more »
Yes, ThinkHouse is a place where eight young entrepreneurs, all in their early 20s, apply for a chance to live under the same roof for nine months while they start their own businesses. But here are some images to put out... Read more »
If you’ve made a retail purchase recently, chances are good you used technology developed in Research Triangle Park without even realizing it.
The modern day barcode has its origins in the 1970s research of IBM scientists Joseph Woodland and George Laurer.... Read more »
Innovation, North Carolina style—at last.
Ever since writing the original Xconomy business plan, I’ve been looking forward to the day when we began covering innovation in the Tar Heel state. Now, I am extremely happy to announce, that day has come.... Read more »
When Roger Pomerantz, the CEO of Cambridge, MA-based Seres Health said last week that he’s preparing to take his company public off of a promising, early study, it wasn’t just the natural next step for a biotech startup. It also marked... Read more »
In an industry obsessed with creating the next big thing, it can be easy to forget that a lot of big ideas simply crash and burn.
So here’s a little reminder: Last year, American venture capitalists put together their best annual... Read more »
The plan for Wisconsin’s new fund-of-funds program is starting to come into focus.
The headline: The Badger Fund of Funds could ultimately result in at least five new funds investing a minimum of $90 million in more than 100 Wisconsin startups... Read more »